This study follows 23 people who received a special lens implant that slowly releases glaucoma medication during cataract surgery. Researchers want to see if the implant keeps eye pressure low and vision clear for up to 7 years. Participants already completed an earlier study and…
Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated May 17, 2026 10:40 UTC